跳至主要内容
临床试验/KCT0001055
KCT0001055招募中未知

Genetic Biomarker Research for Personalized Therapy of Chorioretinal Neovascular Diseases

Inje University Busan Paik Hospital0 个研究点目标入组 1,000 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
50(Year) 至 o Limit(—)
性别
All

入选标准

  • (1) Patients written consent to participate in research
  • (2) Patients written consent to genetic test and Research agreement
  • (3) Adults more than 50 years old
  • (4) Macular degeneration caused by chorioretinal neovascularization patients and diabetic retinopathy patients diagnosed with slit lamp examination, fundus photography, optical coherence tomography(OCT), fluorescein angiography or indocyanine angiographic.
  • (5) Macular degeneration caused by chorioretinal neovascularization patients and diabetic retinopathy patients not diagnosed with slit lamp examination, fundus photography, optical coherence tomography(OCT), fluorescein angiography or indocyanine angiographic.

排除标准

  • 1) Patients with soft drusen or atrophic macular degeneration not accompanied by chorioretinal neovascularization
  • 2) difficult Patients to observe the fundus because of moderate to severe cataract
  • 3) The possibility of pregnancy in patients.
  • However, No surgery for female infertility of childbearing age can participate in a clinical trial after the interview pregnancy
  • 4) The Case legally, mentally unsuitable for participation in a clinical trial if the investigator

研究者

相似试验